tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Hoang, 6 are a BUY (46.15%), 5 are a HOLD (38.46%), 2 are a SELL (15.38%).
Analyst David Hoang works with a stock forecast success ratio of 33.33% fulfilled within 81.71 days on average. Previously, David Hoang worked at SMBC NIKKO.
David Hoang’s has documented 26 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on SRPT, Sarepta Therapeutics at 29-Feb-2024.
Analyst best performing recommendations are on SRPT (SAREPTA THERAPEUTICS).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 12/13/2023. The price target of $113 was fulfilled within 27 days with a profit of $20.89 (22.68%) receiving and performance score of 8.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
16
$-0.7 (-4.19%)
22
6 months 15 days ago
1/2 (50%)
$0.05 (0.31%)
1
Buy
15
$-1.7 (-10.18%)
15
9 months 24 days ago
2/2 (100%)
$9.77 (186.81%)
146
Buy
10 months 7 days ago
1/2 (50%)
$88 (107.32%)
428
Buy
5
$-11.7 (-70.06%)
1 years 1 months 7 days ago
1/1 (100%)
$0.05 (1.01%)
1
Buy
13
1 years 11 months 7 days ago
1/2 (50%)
$-34.2 (-72.46%)
481
Which stock is David Hoang is most bullish on?
Which stock is David Hoang is most reserved on?
What Year was the first public recommendation made by David Hoang?
